Pierre Quartier

22.6k citations

239 papers · 8.8k · 2 hit papers · h-index 48

Impact in

Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- IL-33, ST2, and ILC Pathways

Papers in

Hematology 120
- Autoimmune and Inflammatory Disorders Research 112
Rheumatology 81
- Systemic Lupus Erythematosus Research 25

Co-authors: Anne‐Marie Prieur (18 shared papers)Brigitte Bader‐Meunier (66 shared papers)Isabelle Koné‐Paut (22 shared papers)Alain Fischer (11 shared papers)Geneviève de Saint Basile (4 shared papers)Bénédicte Neven (15 shared papers)Helen J. Lachmann (7 shared papers)Jean‐Laurent Casanova (10 shared papers)
Journals: Pediatric Rheumatology (30 papers)Annals of the Rheumatic Diseases (26 papers)Lara D. Veeken (19 papers)The Journal of Rheumatology (8 papers)Arthritis & Rheumatology (7 papers)
Partner nations: France United States Italy

In The Last Decade

Pierre Quartier

215 papers receiving 8.6k citations

Pierre Quartier's Hit Papers

align trajectories log scale

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome 2009 · 627 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 New England Journal of Medicine
2002 The American Journal of Human Genetics

Peers

Countries citing papers authored by Pierre Quartier

Since Specialization

Citations

This map shows the geographic impact of Pierre Quartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Quartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Quartier more than expected).

Fields of papers citing papers by Pierre Quartier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Quartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Quartier. The network helps show where Pierre Quartier may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Quartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Quartier Line = papers co-authored together Pierre Quartier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome New England Journal of Medicine ·Helen J. Lachmann, Isabelle Koné‐Paut, Jasmin Kuemmerle‐Deschner, Kieron Leslie, É. Hachulla, Pierre Quartier, Xavier Gitton, A. Widmer, Neha Patel, Philip N. Hawkins Hit paper breakdown →	2009	627
2	Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes The American Journal of Human Genetics ·Jérôme Feldmann, Anne‐Marie Prieur, Pierre Quartier, Patrick Berquin, Stéphanie Certain, Elisabetta Cortis, D Teillac-Hamel, Alain Fischer, Geneviève de Saint Basile Hit paper breakdown →	2002	544
3	A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Annals of the Rheumatic Diseases ·Pierre Quartier, Florence Allantaz, Rolando Cimaz, Pascal Pillet, Claude Messiaen, Christophe Bardin, Xavier Bossuyt, Anne Boutten, Jacques Bienvenu, A. Duquesne, Olivier Richer, Damien Chaussabel, A. Mogenet, Jacques Banchereau, Jean‐Marc Tréluyer, Paul Landais, Virginia Pascual	2010	381
4	Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients Annals of Oncology ·Nöel Milpied, B. Vasseur, Nathalie Parquet, J. L. Garnier, C. Antoine, Pierre Quartier, Anne‐Sophie Carret, Didier Bouscary, Albert Faye, B. Bourbigot, Yves Réguerre, A.-M. Stoppa, Pascal Bourquard, Bruno Hurault de Ligny, F. Dubief, A. Mathieu-Boué, V. Leblond	2000	285
5	Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France Annals of the Rheumatic Diseases ·Thierry Lequerré, Pierre Quartier, David Rosellini, F.Z. Alaoui, Michel De Bandt, O. Mejjad, Isabelle Koné‐Paut, M Michel, E. Dernis, Meheni Khellaf, Nicolas Limal, C Job-Deslandre, Bruno Fautrel, Xavier Le Loët, Jean Sibilia	2007	281
6	Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type Arthritis & Rheumatism ·Pierre Quartier, Pierre Taupin, Franck Bourdeaut, I. Lemelle, Pascal Pillet, M Bost, Jean Sibilia, Isabelle Koné‐Paut, S. Gandon-Laloum, Marc LeBideau, Brigitte Bader‐Meunier, Richard Mouy, Marianne Debré, Paul Landais, Anne‐Marie Prieur	2003	262
7	Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients The Journal of Pediatrics ·Pierre Quartier, Marianne Debré, J. de Blic, Rodolphe de Sauverzac, N. Sayegh, Nada Jabado, Élie Haddad, S. Blanche, Jean‐Laurent Casanova, Smith Rjh, Françoise Le Deist, Geneviève de Saint Basile, Alain Fischer	1999	227
8	Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children Annals of Intensive Care ·Marion Grimaud, Julie Starck, Michaël Levy, Clémence Marais, Judith Chareyre, Diala Khraiche, Marianne Leruez‐Ville, Pierre Quartier, Pierre Louis Léger, Guillaume Geslain, Nada Semaan, Florence Moulin, Matthieu Bendavid, Sandrine Jean, Géraldine Poncelet, Sylvain Renolleau, Mehdi Oualha	2020	223
9	Protein kinase D at the Golgi controls NLRP3 inflammasome activation The Journal of Experimental Medicine ·Zhirong Zhang, G Mészáros, Wanting He, Yanfang Xu, Helena de Fatima Magliarelli, Laurent Mailly, Michael Mihlan, Yansheng Liu, Marta Puig Gámez, Alexander Goginashvili, Adrien Pasquier, Olga Bielska, Bénédicte Neven, Pierre Quartier, Ruedi Aebersold, Thomas F. Baumert, Philippe Georgel, Jiahuai Han, Roméo Ricci	2017	218
10	Autoimmunity in Wiskott-Aldrich Syndrome: Risk Factors, Clinical Features, and Outcome in a Single-Center Cohort of 55 Patients PEDIATRICS ·Sophie Dupuis‐Girod, Jacques Médioni, Élie Haddad, Pierre Quartier, Marina Cavazzana, Françoise Le Deist, Geneviève de Saint Basile, J. Delaunay, Klaus Schwarz, Jean‐Laurent Casanova, Stéphane Blanche, Alain Fischer	2003	214
11	Long‐term efficacy of the interleukin‐1 receptor antagonist anakinra in ten patients with neonatal‐onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome Arthritis & Rheumatism ·Bénédicte Neven, Isabelle Marvillet, C. Terrada, A Ferster, Nathalie Boddaert, V. Couloignier, Graziella Pinto, Anne Pagnier, Christine Bodemer, Bahram Bodaghi, Marc Tardieu, A M Prieur, Pierre Quartier	2009	178
12	Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency Clinical Immunology ·Pierre Quartier, Jacinta Bustamante, Özden Sanal, Alessandro Plebani, Marianne Debré, Anne Deville, Jiří Litzman, Jacov Levy, Jean‐Paul Fermand, Peter J. L. Lane, Gerd Horneff, Güzide Aksu, Işık Yalçin, Graham Davies, İlhan Tezcan, Furgen Ersoy, Nadia Catalan, Kohsuhe Imai, Alain Fischer, Anne Durandy	2003	172
13	A Large National Cohort of French Patients With Chronic Recurrent Multifocal Osteitis Arthritis & Rheumatology ·J. Wipff, Félicie Costantino, I. Lemelle, C. Pajot, A. Duquesne, Mathie Lorrot, Albert Faye, Brigitte Bader‐Meunier, Karine Brochard, V. Despert, Sylvie Jean, M. Grall‐Lerosey, Y. Marot, D. Nouar, Anne Pagnier, Pierre Quartier, C Job-Deslandre	2014	172
14	Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature Seminars in Arthritis and Rheumatism ·Ulrich Meinzer, Pierre Quartier, Jean‐François Alexandra, Véronique Hentgen, F. Rétornaz, Isabelle Koné‐Paut	2011	157
15	Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells The Journal of Immunology ·Paul Potter, Josefina Cortés-Hernández, Pierre Quartier, Marina Botto, Mark Walport	2003	142
16	RNA recognition by human TLR8 can lead to autoimmune inflammation The Journal of Experimental Medicine ·Cristiana Guiducci, Mei Gong, Alma‐Martina Cepika, Zhaohui Xu, Claudio Tripodo, Lynda Bennett, Chad Crain, Pierre Quartier, John J. Cush, Virginia Pascual, Robert L. Coffman, Franck J. Barrat	2013	139
17	A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features Arthritis & Rheumatism ·Nicolino Ruperto, Pierre Quartier, Nico Wulffraat, Patricia Woo, Angelo Ravelli, Richard Mouy, Brigitte Bader‐Meunier, Sebastiaan J. Vastert, Emanuele Noseda, Daniele D’Ambrosio, Jean Lecot, Abhijit Chakraborty, Alberto Martini, Andrea Chioato	2011	135
18	Predominant role of IgM‐dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow‐derived macrophages in vitro European Journal of Immunology ·Pierre Quartier, Paul Potter, Michael R. Ehrenstein, Mark Walport, Marina Botto	2004	133
19	Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - a report from the French Society of Pediatric Oncology Annals of Oncology ·Laurence Brugières, Pierre Quartier, Marie‐Cécile Le Deley, Hélène Pacquement, Yves Pérel, Christophe Bergeron, Claudine Schmitt, J Landmann, Catherine Patte, M.-J. Terrier-Lacombe, Georges Delsol, Olivier Hartmann	2000	117
20	Clinical outcome in children with chronic recurrent multifocal osteomyelitis Lara D. Veeken ·Charlotte Catalano‐Pons, Aurélie Comte, J. Wipff, Pierre Quartier, Albert Faye, D Gendrel, A. Duquesne, Rolando Cimaz, C Job-Deslandre	2008	117

About Pierre Quartier

Pierre Quartier is a scholar working on Hematology, Rheumatology, Speech and Hearing, Immunology and Molecular Biology, having authored 239 papers that have together received 8.8k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (112 papers), Adolescent and Pediatric Healthcare (53 papers), Inflammasome and immune disorders (43 papers), Acute Lymphoblastic Leukemia research (29 papers), Systemic Lupus Erythematosus Research (25 papers), Immunodeficiency and Autoimmune Disorders (21 papers), Ocular Diseases and Behçet’s Syndrome (21 papers) and Inflammatory Myopathies and Dermatomyositis (20 papers). The work is most often cited by research in Hematology (3.1k citations), Immunology (3.4k citations), Rheumatology (1.8k citations), Speech and Hearing (795 citations) and Nephrology (594 citations). Pierre Quartier has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Anne‐Marie Prieur, Brigitte Bader‐Meunier, Isabelle Koné‐Paut, Alain Fischer, Geneviève de Saint Basile, Bénédicte Neven, Helen J. Lachmann, Jean‐Laurent Casanova, Philip N. Hawkins and Stéphanie Certain. Their work appears in journals such as Pediatric Rheumatology, Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Rheumatology and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Pierre Quartier

Impact in

Papers in i

In The Last Decade

Pierre Quartier

Pierre Quartier's Hit Papers

Peers

Countries citing papers authored by Pierre Quartier

Fields of papers citing papers by Pierre Quartier

All Works

About Pierre Quartier

Explore authors with similar magnitude of impact

Papers in